Stay updated on Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial

Sign up to get notified when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:26:16.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the levels of autoantibodies against glucose regulated protein 78 (GRP78) among patients with pulmonary emphysema attributable to cigarette smoking in the study.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:28.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that researchers are looking for individuals with a history of significant tobacco smoking who have quit for over six months, among other health-related criteria. Previously, this section did not provide any information.
    Difference
    43%
    Check dated 2024-05-22T21:19:36.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:26:49.000Z thumbnail image

Stay in the know with updates to Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.